Ruedi Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Ruedi Wealth Management's NVS Position: Q2 2023 in Review
Ruedi Wealth Management sold out of Novartis (NVS) in Q2 2023, closing a stake of 23 shares — an estimated $2.12K sold.
Ruedi Wealth Management first reported a position in NVS in Q4 2022 and held it in 2 quarters. The position peaked at $2.12K in Q1 2023. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.
- Ruedi Wealth Management reported no remaining Novartis position as of Q2 2023 after selling out during the quarter.
- Ruedi Wealth Management sold 23 Novartis shares in Q2 2023, an estimated $2.12K.
- Ruedi Wealth Management first reported a position in Novartis in Q4 2022 and held it in 2 quarters.
- Ruedi Wealth Management's Novartis position peaked at $2.12K in Q1 2023.
- 1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.
Based on Ruedi Wealth Management's 13F filing for Q2 2023, filed 27 Jul 2023.